Xu, Pengfei

Melatonin prevents obesity through modulation of gut microbiota in mice

Xu, P., Wang, J., Hong, F., Wang, S., Jin, X., Xue, T., Jia, L., & Zhai, Y. (2017) · Journal of Pineal Research

Gut microbiota and healthCircadian rhythm and melatonin

Cited by 281

PPARs as Nuclear Receptors for Nutrient and Energy Metabolism

Hong, F., Pan, S., Guo, Y., Xu, P., & Zhai, Y. (2019) · Molecules

Peroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Cited by 233

The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development

Hong, F., Xu, P., & Zhai, Y. (2018) · International Journal of Molecular Sciences

Peroxisome Proliferator-Activated ReceptorsParaoxonase enzyme and polymorphisms

Cited by 139

The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1

Xi, Y., Li, Y., Xu, P., Li, S., Liu, Z., Tung, H.-C., Cai, X., Wang, J., Huang, H., Wang, M., et al. (2021) · Science Advances

Liver physiology and pathologyRedox biology and oxidative stress

Cited by 67

Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota

Pan, S., Guo, Y., Hong, F., Xu, P., & Zhai, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Circadian rhythm and melatoninGut microbiota and health

Cited by 37